Latest news

• Lilly partners with GSK and Vir on COVID-19 antibody study

  antibodies. As part of the deal, Lilly will test a combination of its neutralising antibody bamlanivimab with GSK/Vir’s monoclonal antibody VIR-7831. ... deaths in high-risk COVID-19 patients when combined with its other antibody etesevimab.

• Healthineers’ COVID-19 antibody test launches in EU

  The SARS-CoV-2 IgG Antibody Test (sCOVG) has the ability to detect neutralising antibodies and reports quantitative results, measuring the levels present in a person’s blood sample. ... By measuring neutralising antibody levels, the test could give an

• Roche, Regeneron partner on COVID-19 antibody cocktail

  19. In July, Regeneron advanced the antibody cocktail, REGN-COV2, into a phase 3 trial being jointly run by the US National Institute of Allergy and Infectious Diseases (NIAID). ... Following that, Roche also secured an EUA from the FDA for its COVID-19

• Healthineers’ COVID-19 antibody test proves most effective in comparative study

  Beats tests from Roche, Abbott and DiaSorin. In a comparative study conducted by Public Health England in partnership with Oxford University, Siemens Healthineers’ COVID-19 antibody test proved the most effective ... On the specificity value, the test

• UK-Senegal partners plan to validate ten-minute COVID-19 diagnostic

  The prototype test utilises similar technology to a home pregnancy test, and is set to begin a validation test this week. ... The rapid test uses a saliva-based virus antigen test and a blood-based antibody test, with an easy to understand line appearing